Skip to main content
SpringerLink
Log in

Management of Thyroid Cancer

  • Chapter
  • First Online:
PET/CT in Thyroid Cancer

Part of the book series: Clinicians’ Guides to Radionuclide Hybrid Imaging ((PET/CT))

  • 614 Accesses

Abstract

Please check if identified heading levels are correct.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf). 2014;81:–1, 122.

    Google Scholar 

  2. Department of Health. (2006) Cancer Waiting Times: A Guide (Version 5). London: DH. www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_06306761.

    Google Scholar 

  3. Hambly NM, Gonen M, Gerst SR. Implementation of Evidence-based guidelines for thyroid nodule biopsy: a model for establishment of practice standards. Am J Roentgenol. 2011;196:655–60.

    Article  Google Scholar 

  4. Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer—Chapter 4 Ultrasound assessment of thyroid nodules. Clin Endocrinol (Oxf). 2014;81:14–8.

    Article  Google Scholar 

  5. Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer—Chapter 5 Fine-Needle aspiration cytology. Clin Endocrinol (Oxf). 2014;81:19–20.

    Article  Google Scholar 

  6. Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer—Chapter 3 Presentation, diagnosis and referral. Clin Endocrinol (Oxf). 2014;81:10–1.

    Article  Google Scholar 

  7. Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer—Chapter 7.5 Diagnostic thyroid surgery. Clin Endocrinol (Oxf). 2014;81:26.

    Article  Google Scholar 

  8. Seningen JL, Nassar A, Henry MR. Correlation of thyroid nodule fine-needle aspiration cytology with corresponding histology at Mayo Clinic, 2001-2007: an institutional experience of 1,945 cases. Diagn Cytopathol. 2012;40(Suppl. 1):E27–32.

    Article  PubMed  Google Scholar 

  9. Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer—Chapter 7.6 Therapeutic surgery for thyroid cancer. Clin Endocrinol (Oxf). 2014;81:27.

    Article  Google Scholar 

  10. Hart DM, Leboulleux S, Al Ghuzlan A, et al. Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann Surg. 2012;255:777–83.

    Article  Google Scholar 

  11. Lang BH, Wong KP, Wan KY, et al. Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma. Ann Surg Oncol. 2012;19:60–7.

    Article  PubMed  Google Scholar 

  12. Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer—Chapter 8.3Management of papillary microcarcinoma. Clin Endocrinol (Oxf). 2014;81:33.

    Article  Google Scholar 

  13. Lang W, Choritz H, Hundeshagen H. Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings. Am J Surg Pathol. 1986;10:246–55.

    Article  CAS  PubMed  Google Scholar 

  14. Nagar S, Aschebrook-Kilfoy B, Kaplan EL, et al. Hurthle cell carcinoma: an update on survival over the last 35 years. Surgery. 2013;154:1263–71.

    Article  PubMed  Google Scholar 

  15. Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer—Chapter 7.6 Therapeutic surgery for thyroid cancer. Clin Endocrinol (Oxf). 2014;81:28.

    Article  Google Scholar 

  16. Kushchayeva Y, Duh QY, Kebebew E, et al. Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer. Am J Surg. 2008;195:457–62.

    Article  PubMed  Google Scholar 

  17. Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer—Chapter 7.8 Therapeutic surgery for thyroid cancer. Clin Endocrinol (Oxf). 2014;81:29.

    Article  Google Scholar 

  18. Baek SK, Jung KY, Kang SM, et al. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Thyroid. 2010;20:147–52.

    Article  PubMed  Google Scholar 

  19. Ito Y, Kudo T, Kobayashi K, et al. Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg. 2012;36:1274–8.

    Article  PubMed  Google Scholar 

  20. Farrag T, Lin F, Brownlee N, et al. Is routine dissection of level II-B and V-A necessary in patients with papillary thyroid cancer undergoing lateral neck dissection for FNA-confirmed metastases in other levels. World J Surg. 2009;33:1680–3.

    Article  PubMed  Google Scholar 

  21. Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer—Chapter 9 Radioiodine remnant ablation and therapy for differentiated thyroid cancer. Clin Endocrinol (Oxf). 2014;81:37.

    Article  Google Scholar 

  22. Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer—Chapter 9 Radioiodine remnant ablation and therapy for differentiated thyroid cancer. Clin Endocrinol (Oxf). 2014;81:38.

    Article  Google Scholar 

  23. Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer—Chapter 9.7 Radioiodine remnant ablation and therapy for differentiated thyroid cancer. Clin Endocrinol (Oxf). 2014;81:42.

    Article  Google Scholar 

  24. Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer—Chapter 10.1. External beam radiotherapy for differentiated thyroid cancer. Clin Endocrinol (Oxf). 2014;81:46.

    Article  Google Scholar 

  25. Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer—Chapter 17. Medullary thyroid cancer. Clin Endocrinol (Oxf). 2014;81:69.

    Article  Google Scholar 

  26. Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer—Chapter 17.3. Medullary thyroid cancer. Clin Endocrinol (Oxf). 2014;81:70.

    Article  Google Scholar 

  27. Fife KM, Bower M, Harmer C. Medullary thyroid cancer: the role of radiotherapy in local control. Eur J Surg Oncol. 1996;22:588–91.

    Article  CAS  PubMed  Google Scholar 

  28. Iten F, Müller B, Schindler C, et al. Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: a phase II clinical trial. Clin Cancer Res. 2007;13(Pt 1):6696–702.

    Article  CAS  PubMed  Google Scholar 

  29. Kraeber-Bodéré F, Rousseau C, Bodet-Milin C, et al. Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial. J Nucl Med. 2006;47:247–55.

    PubMed  Google Scholar 

  30. Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer—Chapter 18. Anaplastic thyroid cancer. Clin Endocrinol (Oxf). 2014;81:79–80.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Royal Liverpool University Hospital, Liverpool, UK

    M. P. Rowland & A. J. Waghorn

  2. Department of Nuclear Medicine, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK

    S. Vinjamuri

Authors
  1. M. P. Rowland
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. J. Waghorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Vinjamuri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. P. Rowland .

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom

    Sobhan Vinjamuri

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rowland, M.P., Waghorn, A.J., Vinjamuri, S. (2018). Management of Thyroid Cancer. In: Vinjamuri, S. (eds) PET/CT in Thyroid Cancer. Clinicians’ Guides to Radionuclide Hybrid Imaging(). Springer, Cham. https://doi.org/10.1007/978-3-319-71846-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-71846-0_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-71845-3

  • Online ISBN: 978-3-319-71846-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation